S 239 · 109th Congress 2005–2007, ended

Medicare Enhancements for Needed Drugs Act of 2005

Latest action · Feb 1, 2005 Read twice and referred to the Committee on Finance.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 1, 2005
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Medicare Enhancements for Needed Drugs Act of 2005 - Directs the Comptroller General to review and report to Congress on the retail cost of prescription drugs in the United States during 2000 and 2003, and through April 1, 2006, with an emphasis on the prescription drugs most utilized for individuals age 65 or older.

Requires the Comptroller General to conduct an ongoing study that compares the average retail cost in the United States for each of the 20 most utilized prescription drugs for individuals age 65 or older with: (1) the average prices at which private health plans, the Department of Defense under the Defense Health Program, and the Department of Veterans Affairs acquire each such drug; and (2) the average negotiated price for each such drug that eligible beneficiaries have access to under a Medicare prescription drug plan providing only basic prescription drug coverage.

Amends title XVIII (Medicare) of the Social Security Act (SSA) to include in the comparative plan information for beneficiaries under new Medicare part D (Voluntary Prescription Drug Benefit Program) a comparison of average aggregate prescription drug plan beneficiary costs and savings with such costs for a beneficiary with no prescription drug plan.

Repeals the prohibition against interference by the Secretary with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors, as well as the requirement of a particular formulary to institute a price structure for the reimbursement of Medicare part D covered drugs. Authorizes the Secretary instead, like other Federal entities that purchase prescription drugs in bulk, to negotiate contracts with manufacturers of covered part D drugs.

Cosponsors 8

Members who signed on, in the order they did. Signatures ran from Feb 1, 2005 to Mar 8, 2006; 4 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-CADianne FeinsteinOriginalFeb 1, 2005
R-AZJohn McCainOriginalFeb 1, 2005
D-ORRon WydenOriginalFeb 1, 2005
D-WIRussell D. FeingoldOriginalFeb 1, 2005
D-COKen SalazarFeb 8, 2005
D-FLBill NelsonFeb 10, 2005
D-MAEdward M. KennedyFeb 17, 2005
R-RILincoln ChafeeMar 8, 2006

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateFinance Committee
Referred Feb 1, 2005

Actions 3

Everything that happened, newest first.

  1. Feb 1, 2005Introduced in Senate
  2. Feb 1, 2005Sponsor introductory remarks on measure. (CR S745-746)
  3. Feb 1, 2005Read twice and referred to the Committee on Finance.

In the Congressional Record 7

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S358Ron Wyden D-ORJan 31, 2006
SenateDebate and remarks S1597Ron Wyden D-ORFeb 17, 2005
SenateDebate and remarks S1321Ron Wyden D-ORFeb 14, 2005
SenateDebate and remarks S1252, S1253Bill Nelson D-FL, Ron Wyden D-ORFeb 10, 2005
SenateDebate and remarks S1152Ron Wyden D-ORFeb 9, 2005
SenateDebate and remarks S877Russell D. Feingold D-WIFeb 2, 2005
SenateDebate and remarks S745–S747Dianne Feinstein D-CA, Olympia J. Snowe R-ME, Ron Wyden D-ORFeb 1, 2005

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 109-114CONCURRENT RESOLUTION ON THE BUDGET FOR FISCAL YEAR 2006532 pagesBudget CommitteeFeb 1, 2005–Mar 1, 2005

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to reduce the costs of prescription drugs for medicare beneficiaries, and for other purposes.
Short Titles as Introduced
Medicare Enhancements for Needed Drugs Act of 2005

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Feb 1, 2005Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.